[{"Assets_0_Q1_USD":98785000.0,"CommonStockSharesOutstanding_0_Q1_shares":162528000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11990000.0,"NetIncomeLoss_1_Q1_USD":-5539000.0,"StockholdersEquity_0_Q1_USD":42668000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20190502"}]